2m 2m 2m 2m 2m 2m 2m
CARDIFF ONCOLOGY (CRDF)
NASDAQ
$1.44+$0.04 (+3.14%)
Price as of Jun 03, 2026 7:57 PM EDT- $129.9MMarket Cap
- -61.33%1-Year Change
- BiotechnologyIndustry
CARDIFF ONCOLOGY (CRDF)
$1.44+$0.04 (+3.14%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 593,000 -13.18% | 683,000 +39.96% | 488,000 +26.42% | 386,000 +7.52% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 593,000 -13.18% | 683,000 +39.96% | 488,000 +26.42% | 386,000 +7.52% | |
Sales and Marketing Expense | 14.2M +13.96% | 12.5M -4.30% | 13.0M -1.05% | 13.2M +11.34% | |
Research and Development Expense | -35.3M -4.13% | -36.9M +12.16% | -32.9M +21.21% | -27.1M +56.00% | |
Depreciation and Amortization Expense | 364,000 -9.90% | 404,000 +1.51% | 398,000 +68.64% | 236,000 -47.67% | |
Total Operating Expenses | 49.6M +0.44% | 49.3M +7.48% | 45.9M +13.93% | 40.3M +37.91% | |
Operating Profit | -49.0M +0.64% | -48.7M +7.13% | -45.4M +13.81% | -39.9M +38.28% | |
Interest Income | 3.1M -4.76% | 3.3M -19.91% | 4.1M +157.37% | 1.6M +498.86% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 3.1M -4.76% | 3.3M -19.91% | 4.1M +157.37% | 1.6M +498.86% | |
Total Nonoperating Income and Expense | 3.1M -3.45% | 3.2M -18.91% | 4.0M +231.47% | 1.2M +112.41% | |
Income before Taxes | -45.9M +0.93% | -45.5M +9.62% | -41.5M +7.07% | -38.7M +36.78% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -45.9M +0.92% | -45.4M +9.63% | -41.4M +7.07% | -38.7M +36.81% | |
Net Income from Continuing Operations Applicable to Common | -45.9M +0.93% | -45.5M +9.62% | -41.5M +7.07% | -38.7M +36.78% | |
Basic EPS and Net Income | -0.69 -27.37% | -0.95 +2.15% | -0.93 +4.49% | -0.89 +21.92% | |
Diluted EPS and Net Income | -0.69 -27.37% | -0.95 +2.15% | -0.93 +4.49% | -0.89 +21.92% | |
Basic Weighted Average Shares | 66.8M +40.27% | 47.6M +6.65% | 44.7M +2.47% | 43.6M +11.71% | |
Diluted Weighted Average Shares | 66.8M +40.27% | 47.6M +6.65% | 44.7M +2.47% | 43.6M +11.71% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.5M -66.06% | 51.5M +137.68% | 21.7M +32.47% | 16.3M +36.88% | |
Short-Term Investments | 40.8M +1.39% | 40.3M -24.25% | 53.2M -40.21% | 88.9M -31.00% | |
Cash and Cash Equivalents and Short-Term Investments | 58.3M -36.45% | 91.7M +22.62% | 74.8M -28.92% | 105.3M -25.25% | |
Total Current Assets | 60.1M -36.74% | 95.1M +22.79% | 77.4M -30.44% | 111.3M -23.84% | |
Accumulated Depreciation | 4.5M +7.98% | 4.1M +10.26% | 3.8M +9.93% | 3.4M -0.81% | |
Property and Plant and Equipment and Net | 578,000 -35.63% | 898,000 -27.46% | 1.2M -2.44% | 1.3M +232.20% | |
Total Long-Term Assets | 549,000 +695.65% | 69,000 -94.61% | 1.3M -7.79% | 1.4M +480.33% | |
Total Assets | 61.9M -36.33% | 97.2M +19.05% | 81.6M -29.74% | 116.2M -22.30% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 16.4M +22.09% | 13.4M +28.62% | 10.4M +33.71% | 7.8M +19.04% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 102,000 -87.45% | 813,000 -44.24% | 1.5M -28.53% | 2.0M N/A | |
Total Liabilities | 16.5M +15.83% | 14.2M +19.69% | 11.9M +20.82% | 9.8M +7.90% | |
Retained Earnings | -430.0M +11.93% | -384.2M +13.15% | -339.5M +13.90% | -298.1M +14.74% | |
Total Stockholders Equity | 45.4M -45.28% | 82.9M +18.94% | 69.7M -34.42% | 106.3M -24.27% | |
Total Shares Outstanding | 68.3M +2.68% | 66.5M +48.90% | 44.7M 0.00% | 44.7M +6.47% | |
Cash Flow | |||||
Cash from Operating Activities | -37.9M +0.61% | -37.7M +22.04% | -30.9M -8.67% | -33.8M +46.79% | |
Capital Expenditures | 44,000 -45.00% | 80,000 -86.25% | 582,000 -42.15% | 1.0M +390.73% | |
Cash from Investing Activities | 1.3M -90.22% | 13.7M -62.07% | 36.2M -5.12% | 38.1M +129.02% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.6M -95.20% | 53.8M N/A | 0 -100.00% | 75,000 -99.79% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -8,256.32% +15.91% | -7,123.13% -23.45% | -9,305.74% -9.98% | -10,337.31% +28.61% | |
Return on Assets | -57.65% +13.46% | -50.81% +21.28% | -41.90% +43.83% | -29.13% +46.35% | |
Return on Equity | -71.45% +20.07% | -59.51% +26.42% | -47.07% +50.05% | -31.37% +48.90% | |
Revenue Growth | -13.18% -132.98% | 39.96% +51.22% | 26.42% +251.35% | 7.52% +493.62% | |
Current Ratio | 3.67 -48.19% | 7.08 -4.53% | 7.41 -47.98% | 14.25 -36.03% | |
Cash Ratio | 1.07 -72.20% | 3.83 +84.79% | 2.07 -0.93% | 2.09 +14.98% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow